On April 17, the Palleos and Starodub hosted a webinar which brought together professionals from across the clinical research field to explore practical strategies for navigating the complex regulatory environment of the European Union. Hosted by industry experts Philip Raeth (Managing Director, Palleos), Polina Shatrova (Head of Budgets and Proposals, Palleos), and Valentyna Starodub (CEO, Starodub BV), the session offered actionable insights on aligning regulatory and financial strategies from the earliest stages of trial planning.
This webinar was specifically tailored for Chinese biotech and pharma representatives, organized in response to numerous sponsor requests and the growing interest in accessing the European market. Attendees gained valuable guidance on engaging with EMA through ITF meetings, Scientific Advice, and ODD designation, designing cost-effective trials, and accelerating approvals using tools like PRIME and Adaptive Pathways.
Missed the session? Watch the video recap to catch up on the key insights shared by our experts. If you have any questions about clinical trial planning, regulatory strategy, or market access in the EU, don’t hesitate to reach out — we’re here to help you navigate your next steps with confidence.
